INTRAVESICAL BACILLUS CALMETTE-GUERIN (BCG) AND INTERFERON ALPHA-2B IN THE TREATMENT OF SUPERFICIAL BLADDER CANCER - A CLINICAL AND IMMUNOLOGICAL STUDY
Master's
Saved in:
Main Author: | |
---|---|
Other Authors: | |
Format: | Theses and Dissertations |
Published: |
2020
|
Subjects: | |
Online Access: | https://scholarbank.nus.edu.sg/handle/10635/177083 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
id |
sg-nus-scholar.10635-177083 |
---|---|
record_format |
dspace |
spelling |
sg-nus-scholar.10635-1770832024-10-26T19:43:49Z INTRAVESICAL BACILLUS CALMETTE-GUERIN (BCG) AND INTERFERON ALPHA-2B IN THE TREATMENT OF SUPERFICIAL BLADDER CANCER - A CLINICAL AND IMMUNOLOGICAL STUDY RAVURU SUBRAMANYAM MOHAN SURGERY Bladder cancer Low-dose BCG Interferon alpha-2b Safety Efficacy Drug Toxicity Cytokines Master's MASTER OF SCIENCE 2020-10-05T04:57:20Z 2020-10-05T04:57:20Z 1999 Thesis RAVURU SUBRAMANYAM MOHAN (1999). INTRAVESICAL BACILLUS CALMETTE-GUERIN (BCG) AND INTERFERON ALPHA-2B IN THE TREATMENT OF SUPERFICIAL BLADDER CANCER - A CLINICAL AND IMMUNOLOGICAL STUDY. ScholarBank@NUS Repository. https://scholarbank.nus.edu.sg/handle/10635/177083 CCK BATCHLOAD 20201023 |
institution |
National University of Singapore |
building |
NUS Library |
continent |
Asia |
country |
Singapore Singapore |
content_provider |
NUS Library |
collection |
ScholarBank@NUS |
topic |
Bladder cancer Low-dose BCG Interferon alpha-2b Safety Efficacy Drug Toxicity Cytokines |
spellingShingle |
Bladder cancer Low-dose BCG Interferon alpha-2b Safety Efficacy Drug Toxicity Cytokines RAVURU SUBRAMANYAM MOHAN INTRAVESICAL BACILLUS CALMETTE-GUERIN (BCG) AND INTERFERON ALPHA-2B IN THE TREATMENT OF SUPERFICIAL BLADDER CANCER - A CLINICAL AND IMMUNOLOGICAL STUDY |
description |
Master's |
author2 |
SURGERY |
author_facet |
SURGERY RAVURU SUBRAMANYAM MOHAN |
format |
Theses and Dissertations |
author |
RAVURU SUBRAMANYAM MOHAN |
author_sort |
RAVURU SUBRAMANYAM MOHAN |
title |
INTRAVESICAL BACILLUS CALMETTE-GUERIN (BCG) AND INTERFERON ALPHA-2B IN THE TREATMENT OF SUPERFICIAL BLADDER CANCER - A CLINICAL AND IMMUNOLOGICAL STUDY |
title_short |
INTRAVESICAL BACILLUS CALMETTE-GUERIN (BCG) AND INTERFERON ALPHA-2B IN THE TREATMENT OF SUPERFICIAL BLADDER CANCER - A CLINICAL AND IMMUNOLOGICAL STUDY |
title_full |
INTRAVESICAL BACILLUS CALMETTE-GUERIN (BCG) AND INTERFERON ALPHA-2B IN THE TREATMENT OF SUPERFICIAL BLADDER CANCER - A CLINICAL AND IMMUNOLOGICAL STUDY |
title_fullStr |
INTRAVESICAL BACILLUS CALMETTE-GUERIN (BCG) AND INTERFERON ALPHA-2B IN THE TREATMENT OF SUPERFICIAL BLADDER CANCER - A CLINICAL AND IMMUNOLOGICAL STUDY |
title_full_unstemmed |
INTRAVESICAL BACILLUS CALMETTE-GUERIN (BCG) AND INTERFERON ALPHA-2B IN THE TREATMENT OF SUPERFICIAL BLADDER CANCER - A CLINICAL AND IMMUNOLOGICAL STUDY |
title_sort |
intravesical bacillus calmette-guerin (bcg) and interferon alpha-2b in the treatment of superficial bladder cancer - a clinical and immunological study |
publishDate |
2020 |
url |
https://scholarbank.nus.edu.sg/handle/10635/177083 |
_version_ |
1821191629771374592 |